RxDoctor Payments Data

Laurie Warren

Physician Assistant · Sioux City, IANPI 1710941000

Payments from drug & device makers

$2,697in general payments, 2019–2025

Across 153 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$581
  • Alkermes, Inc.$561
  • Otsuka America Pharmaceutical, Inc.$474
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$243
  • AbbVie$213
  • Johnson & Johnson$181
  • plus $443 from 5 others

What the payments were for

  • Food & beverage$2,57796%
  • Education$1204%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,697 in reported general payments places this provider in the 90th percentile of 1,140 physician assistant providers in Iowa.

See all physician assistant providers in Iowa

Medicare billing

Part B allowed, 2024
$77,188
Medicare patients
192
Services billed
1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate74$230,571
Invega TrinzaPaliperidone Palmitate11$98,468
AustedoDeutetrabenazine15$64,823
AristadaAripiprazole Lauroxil22$63,848
VraylarCariprazine Hcl44$57,476
RexultiBrexpiprazole42$46,832
Abilify MaintenaAripiprazole11$35,971
Aripiprazole424$34,786
Lurasidone Hcl162$25,486
Risperdal ConstaRisperidone Microspheres13$23,581
NuedextaDextromethorphan Hbr/Quinidine18$21,609
Paliperidone ErPaliperidone99$20,443
Divalproex Sodium ErDivalproex Sodium242$16,306
Clozapine264$14,775
VyvanseLisdexamfetamine Dimesylate24$14,570

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$181$352,62098 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$474$82,80353 claims
Teva Pharmaceuticals USA, Inc.Austedo$581$64,82315 claims
Alkermes, Inc.Aristada$561$63,84822 claims
AbbVieVraylar$213$57,47644 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$58$14,57024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,140 physician assistant providers in Iowa.

Other physician assistant in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →